Form 4 for CC Chemours Co
Accepted 2023-08-03 00:00:00 ET · period of report 2023-08-01 · accession 0001209191-23-044505 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-03 | 2023-08-01 | CC | Abbott Matthew S | SVP, Chief Enterprise Transfor | A - Grant | $0.00 | +4,069 | 34.0K | +14% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-01 | A | A | 4,069 | $0.00 | 34,044.30 | D | — | — | (F1) Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on August 1, 2024. (F2) Includes directly owned shares, stock units and dividend equivalent units. |